poisar

Stock

Tonix Pharmaceuticals Holding Corp. TNXP

$9.79-2.97%

Overview

TNXP market data

Price History

TNXP price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$14.57
Diluted earnings per share over the trailing twelve months.
Beta
1.72
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$9.40 – $69.97
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $151.6 · P/B 0.81 · P/S 8.64.

Company News

10 captured
8-K filing — Tonix Pharmaceuticals Holding Corp. (TNXP)SEC EDGAR · Jul 21, 2026, 8:05 PM
Tonix Pharma Announces Publication Of Monkeypox Study In Journal Of Virology, Peer-Reviewed Publication Of ASMBenzinga · Jul 15, 2026, 1:07 PM
Tonix Secures Medicare Coverage For Fibromyalgia Drug TONMYA, Expands TONMYA Coverage To 145M Lives By 2027Benzinga · Jul 13, 2026, 11:07 AM
Tonix Pharmaceuticals Enrolled First Patient In Phase 2 HORIZON Study Of TNX-102 SL For MDD; Primary Endpoint Is Change In MADRS Total Score At Week 6Benzinga · Jun 29, 2026, 11:15 AM
This Keurig Dr Pepper Analyst Turns Bullish; Here Are Top 4 Upgrades For ThursdayBenzinga · Jun 25, 2026, 4:25 PM
This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For ThursdayBenzinga · Jun 25, 2026, 2:20 PM
This Tonix Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For ThursdayBenzinga · Jun 25, 2026, 12:50 PM
Tonix Shares Jump After Landing Second Commercial Payer Agreement For TONMYABenzinga · Jun 8, 2026, 12:45 PM
Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. LivesGlobenewswire Inc · Jun 8, 2026, 11:15 AM
Tonix Pharmaceuticals Enters Agreement With A Group Purchasing Organization To Provide Coverage For TONMYA To An Additional ~17M U.S. Commercial Lives From June 1Benzinga · Jun 8, 2026, 11:15 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock